293758-83-5 Usage
Pyrazole derivative
A class of organic compounds with a five-membered ring containing two nitrogen atoms The compound belongs to this class, which is known for its various applications in pharmaceuticals and other industries.
Carboxylic acid
Contains a carboxyl group (-COOH) attached to the pyrazole ring This property makes the compound an acid with acidic properties, which can participate in various chemical reactions.
Pharmaceutical research
Used as a building block for the synthesis of new drugs, particularly those targeting the central nervous system The compound has potential applications in the development of medications for various central nervous system-related disorders.
Potential applications
Agrochemicals and material science Due to its unique structure and properties, the compound may also find use in agriculture and material science industries.
Check Digit Verification of cas no
The CAS Registry Mumber 293758-83-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,3,7,5 and 8 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 293758-83:
(8*2)+(7*9)+(6*3)+(5*7)+(4*5)+(3*8)+(2*8)+(1*3)=195
195 % 10 = 5
So 293758-83-5 is a valid CAS Registry Number.
293758-83-5Relevant articles and documents
Adamantyl-pyrazole carboxamides as inhibitors of 11B-hydroxysteroid dehydrogenase
-
Page/Page column 16-17, (2008/06/13)
Provided herein are compounds of the formula (I): as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, type II diabetes mellitus and metabolic syndrome.
Synthesis of novel pyrazolopyrrolopyrazines, potential analogs of sildenafil
Kopp,Lancelot,Dallemagne,Rault
, p. 1045 - 1050 (2007/10/03)
Synthesis of novel pyrazolopyrrolopyrazines is herein described with the aim to reach new specific PDE-5 inhibitors of potential clinical interest in male erectile dysfunction.
